4-AcO-DMT to 2C-I
On his own, legendary chemist Alexander “Sasha” Shulgin discovered, synthesized, and analyzed more than 230 psychoactive compounds, including MDMA (which he synthesized and popularized decades after a German pharmaceutical company formulated it in 1912), as well as compounds of the 2C family, such as 2C-B (which is often compared to a hybrid of MDMA and magic mushrooms). For decades, underground chemists and devout psychonauts have also tinkered with mind-bending substances and used themselves as guinea pigs to chronicle the bizarre, divine, and sometimes outright terrifying on message boards like Reddit and Erowid, the digital encyclopedia of psychedelic reports. Today, dozens of scientists are continuing this work, creating novel psychedelics as potential mental health treatments. Chemist Del Potter is one of them. In this webinar, he’ll discuss how new psychedelics are created, as well as introduce us to some of the more obscure analogs that have long graced the underground.
If you cannot afford the suggested sliding scale, email [email protected] to be registered
About Dr. Del Potter
Dr. Del Potter is a medical anthropologist, an entrepreneur, and the Chief Science Officer of Aya Biosciences, a biopharmaceutical startup that develops next-gen therapeutic cannabis and psychedelic compounds.
Dr. Potter earned his PhD in medical anthropology in 1980 through a joint program of UC Berkeley and UCSF Medical School. His doctoral research specialized in psychiatric anthropology, neuropharmacology and ethnopsychopharmacology. He completed his psychotherapy clinical training at San Francisco Psychoanalytic Institute.